Cross-sectional Study of Ultrasonic Diagnosis of Iliac Joint Capsule Muscle

A Cross-sectional Study: the Development of the Hip Joint Was Studied by Measuring the Anatomical Circumference of the Capsular Muscle of the Iliac Joint With Ultrasound Doppler

In order to investigate the relationship between the iliac joint capsular muscle and the development of the hip joint, this study used ultrasound Doppler to measure the anatomical circumference of the iliac joint capsular muscle to explore the relationship

Study Overview

• Status: Completed
• Conditions: Femoroacetabular Impingement; Hip Developmental Dysplasia
• Intervention / Treatment: Device: ultrasound Doppler

Detailed Description

In order to investigate the relationship between the iliac joint capsular muscle and the development of the hip joint, this study used ultrasound Doppler to measure the anatomical circumference of the iliac joint capsular muscle to explore the relationship.Ultrasound was used to compare the size of the iliac joint cystic muscle in the three groups: patients with developmental dysplasia of the hip (DDH), patients with Pincer type femoral hip impingement, and normal control group. The shear wave velocity and shear modulus of the iliac joint capsular muscle of three groups were compared to compare the degree of fat infiltration in muscle.

• Study Type: Observational
• Enrollment (Actual): 132

Contacts and Locations

Study Locations

• China
  • Beijing
    • Beijing, Beijing, China
      • Department of Ultrasound Diagnosis, Peking University Third Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 20 years to 50 years (Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Patients who were admitted to the sports medicine outpatient department of Peking University Third Hospital for hip surgery and volunteers recruited as control group，including 40 patients with developmental dysplasia of the hip 40 femoroacetabular impingement patients and 40 healthy volunteers as the control group.

Description

Inclusion Criteria:

• ≥ 20 years;
• Clinically suspected of DDH or Pincer and underwent surgery
• Understand and sign the informed consent

Exclusion Criteria:

• Leggcalve´-Perthes disease
• Muscle diseases
• Hip development disorder
• History of progressive osteoarthritis
• History of hip surgery
• History of arthritis of the hip joint
• With pacemaker or metal in the body

Study Plan

How is the study designed?

Number of groups / cohorts

3

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
control group; healthy volunteers	Device: ultrasound Doppler; A cross-sectional study:the development of the hip joint was studied by measuring the anatomical circumference of the capsular muscle of the iliac joint with ultrasound Doppler
hip developmental dysplasia group; patients with developmental dysplasia of hip	Device: ultrasound Doppler; A cross-sectional study:the development of the hip joint was studied by measuring the anatomical circumference of the capsular muscle of the iliac joint with ultrasound Doppler
femoroacetabular impingement group; patients with femoroacetabular impingement	Device: ultrasound Doppler; A cross-sectional study:the development of the hip joint was studied by measuring the anatomical circumference of the capsular muscle of the iliac joint with ultrasound Doppler

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Parameter of ultraphonic results	The anatomical circumference of the capsular muscle of the iliac joint was measured by ultrasound Doppler，including the dimensional ultrasonic gram and shear wave elasticity diagram	Ultraphonic was conducted when patients were included in the study from March to October, 2019

Collaborators and Investigators

• Sponsor: Peking University Third Hospital
• Investigators: Principal Investigator: Ligang Cui, Peking University Third Hospital

Study record dates

Study Major Dates

• Study Start (Actual): March 1, 2019
• Primary Completion (Actual): August 30, 2019
• Study Completion (Actual): October 30, 2019

Study Registration Dates

• First Submitted: July 2, 2021
• First Submitted That Met QC Criteria: July 9, 2021
• First Posted (Actual): July 20, 2021

Study Record Updates

• Last Update Posted (Actual): July 20, 2021
• Last Update Submitted That Met QC Criteria: July 9, 2021
• Last Verified: June 1, 2021

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pathologic Processes; Joint Diseases; Musculoskeletal Diseases; Femoracetabular Impingement
• Other Study ID Numbers: M2019122

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No